1
|
Murray CJ and Lopez AD: Alternative
projections of mortality and disability by cause 1990–2020: Global
Burden of Disease Study. Lancet. 349:1498–1504. 1997. View Article : Google Scholar : PubMed/NCBI
|
2
|
Guo J, Miao Y, Xiao B, Huan R, Jiang Z,
Meng D and Wang Y: Differential expression of microRNA species in
human gastric cancer versus non-tumorous tissues. J Gastroenterol
Hepatol. 24:652–657. 2009. View Article : Google Scholar : PubMed/NCBI
|
3
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:pp. 2257–2261.
2006; View Article : Google Scholar : PubMed/NCBI
|
4
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
5
|
Bandrés E, Cubedo E, Agirre X, Malumbres
R, Zárate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzó M, et
al: Identification by Real-time PCR of 13 mature microRNAs
differentially expressed in colorectal cancer and non-tumoral
tissues. Mol Cancer. 5:292006. View Article : Google Scholar : PubMed/NCBI
|
6
|
Zhong X, Coukos G and Zhang L: miRNAs in
human cancerNext-Generation MicroRNA Expression Profiling
Technology: Methods and Protocols, Methods in Molecular Biology.
Fan JB: 822. Humana Press; New York: pp. 295–306. 2012, View Article : Google Scholar
|
7
|
Chiba Y, Tanabe M, Goto K, Sakai H and
Misawa M: Down-regulation of miR-133a contributes to up-regulation
of Rhoa in bronchial smooth muscle cells. Am J Respir Crit Care
Med. 180:713–719. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Zhao H, Li M, Li L, Yang X, Lan G and
Zhang Y: MiR-133b is down-regulated in human osteosarcoma and
inhibits osteosarcoma cells proliferation, migration and invasion,
and promotes apoptosis. PLoS One. 8:e835712013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Hu G, Chen D, Li X, Yang K, Wang H and Wu
W: miR-133b regulates the MET proto-oncogene and inhibits the
growth of colorectal cancer cells in vitro and in vivo. Cancer Biol
Ther. 10:190–197. 2010. View Article : Google Scholar : PubMed/NCBI
|
10
|
Crawford M, Batte K, Yu L, Wu X, Nuovo GJ,
Marsh CB, Otterson GA and Nana-Sinkam SP: MicroRNA 133B targets
pro-survival molecules MCL-1 and BCL2L2 in lung cancer. Biochem
Biophys Res Commun. 388:483–489. 2009. View Article : Google Scholar : PubMed/NCBI
|
11
|
Han Y, Chen J, Zhao X, Liang C, Wang Y,
Sun L, Jiang Z, Zhang Z, Yang R, Chen J, et al: MicroRNA expression
signatures of bladder cancer revealed by deep sequencing. PLoS One.
6:e182862011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM Classification of Malignant Tumours. 7th edition.
Wiley-Blackwell; Hoboken, NJ: 2009
|
13
|
Srere PA: The citrate cleavage enzyme. I.
Distribution and purification. J Biol Chem. 234:2544–2547.
1959.PubMed/NCBI
|
14
|
Migita T, Narita T, Nomura K, Miyagi E,
Inazuka F, Matsuura M, Ushijima M, Mashima T, Seimiya H, Satoh Y,
et al: ATP citrate lyase: Activation and therapeutic implications
in non-small cell lung cancer. Cancer Res. 68:8547–8554. 2008.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Zaidi N, Swinnen JV and Smans K:
ATP-citrate lyase: A key player in cancer metabolism. Cancer Res.
72:3709–3714. 2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Mueller E, Sarraf P, Tontonoz P, Evans RM,
Martin KJ, Zhang M, Fletcher C, Singer S and Spiegelman BM:
Terminal differentiation of human breast cancer through PPARγ. Mol
Cell. 1:465–470. 1998. View Article : Google Scholar : PubMed/NCBI
|
17
|
DuBois RN, Gupta R, Brockman J, Reddy BS,
Krakow SL and Lazar MA: The nuclear eicosanoid receptor, PPARγ, is
aberrantly expressed in colonic cancers. Carcinogenesis. 19:49–53.
1998. View Article : Google Scholar : PubMed/NCBI
|
18
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Kano M, Seki N, Kikkawa N, Fujimura L,
Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M and
Matsubara H: miR-145, miR-133a and miR-133b: Tumor-suppressive
miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J
Cancer. 127:2804–2814. 2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Williams AH, Liu N, van Rooij E and Olson
EN: MicroRNA control of muscle development and disease. Curr Opin
Cell Biol. 21:461–469. 2009. View Article : Google Scholar : PubMed/NCBI
|
21
|
Boštjančič E, Zidar N, Štajer D and Glavač
D: MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated
in human myocardial infarction. Cardiology. 115:163–169. 2010.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Xiang KM and Li XR: MiR-133b acts as a
tumor suppressor and negatively regulates TBPL1 in colorectal
cancer cells. Asian Pac J Cancer Prev. 15:3767–3772. 2014.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Liu L, Shao X, Gao W, Zhang Z, Liu P, Wang
R, Huang P, Yin Y and Shu Y: MicroRNA-133b inhibits the growth of
non-small-cell lung cancer by targeting the epidermal growth factor
receptor. FEBS J. 279:3800–3812. 2012. View Article : Google Scholar : PubMed/NCBI
|
24
|
Wen D, Li S, Ji F, Cao H, Jiang W, Zhu J
and Fang X: miR-133b acts as a tumor suppressor and negatively
regulates FGFR1 in gastric cancer. Tumour Biol. 34:793–803. 2013.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Stewart B and Wild CP: World cancer report
2014. International Agency for Research on Cancer (IARC); Lyon,
France: 2015
|
26
|
Lemberger T, Desvergne B and Wahli W:
Peroxisome proliferator-activated receptors: A nuclear receptor
signaling pathway in lipid physiology. Annu Rev Cell Dev Biol.
12:335–363. 1996. View Article : Google Scholar : PubMed/NCBI
|
27
|
Jiang C, Ting AT and Seed B: PPAR-γ
agonists inhibit production of monocyte inflammatory cytokines.
Nature. 391:82–86. 1998. View
Article : Google Scholar : PubMed/NCBI
|
28
|
Song K, Han C, Zhang J, Lu D, Dash S,
Feitelson M, Lim K and Wu T: Epigenetic regulation of MicroRNA-122
by peroxisome proliferator activated receptor-gamma and hepatitis b
virus X protein in hepatocellular carcinoma cells. Hepatology.
58:1681–1692. 2013. View Article : Google Scholar : PubMed/NCBI
|
29
|
Hatzivassiliou G, Zhao F, Bauer DE,
Andreadis C, Shaw AN, Dhanak D, Hingorani SR, Tuveson DA and
Thompson CB: ATP citrate lyase inhibition can suppress tumor cell
growth. Cancer Cell. 8:311–321. 2005. View Article : Google Scholar : PubMed/NCBI
|
30
|
Bauer DE, Hatzivassiliou G, Zhao F,
Andreadis C and Thompson CB: ATP citrate lyase is an important
component of cell growth and transformation. Oncogene.
24:6314–6322. 2005. View Article : Google Scholar : PubMed/NCBI
|